GSTM1 and mEPHX Polymorphisms in Parkinson's Disease and Age of Onset
- 24 March 2000
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 269 (3) , 676-680
- https://doi.org/10.1006/bbrc.2000.2338
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Association between polymorphism in gene for microsomal epoxide hydrolase and susceptibility to emphysemaThe Lancet, 1997
- Mutation in the α-Synuclein Gene Identified in Families with Parkinson's DiseaseScience, 1997
- Multiple cutaneous basal cell carcinomas: glutathione S-transferase (GSTM1, GSTT1) and cytochrome P450 (CYP2D6, CYP1A1) polymorphisms influence tumour numbers and accrualCarcinogenesis: Integrative Cancer Research, 1996
- Oxidative Stress in Neurodegenerative DiseasesAnnual Review of Pharmacology and Toxicology, 1996
- Increased risk for myelodysplastic syndromes in individuals with glutathione transferase theta 1 (GSTT1) gene defectThe Lancet, 1996
- Genotypic and phenotypic determination of polymorphic glutathione transferase T1 in a Swedish populationPharmacogenetics, 1995
- Radiographic changes and lung function in relation to activity of the glutathione transferases theta and mu among asbestos cement workersToxicology Letters, 1995
- The Glut athione S-Transferase Supergene Family: Regulation of GST and the Contribution of the lsoenzymes to Cancer Chemoprotection and Drug Resistance Part ICritical Reviews in Biochemistry and Molecular Biology, 1995
- Glutathion s‐transferase (class μ) phenotype in Parkinson's diseaseMovement Disorders, 1994
- Genetic Risk and Carcinogen Exposure: a Common Inherited Defect of the Carcinogen-Metabolism Gene Glutathione S-Transferase M1 (GSTM1) That Increases Susceptibility to Bladder CancerJNCI Journal of the National Cancer Institute, 1993